These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 38019052)

  • 1. Commentary on New Fatty Liver Nomenclature: Steatotic Liver Disease.
    Shetty A; Saab S
    J Clin Gastroenterol; 2024 Feb; 58(2):109. PubMed ID: 38019052
    [No Abstract]   [Full Text] [Related]  

  • 2. Validation of the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake: an analysis of data from a prospective cohort study.
    Israelsen M; Torp N; Johansen S; Hansen CD; Hansen ED; Thorhauge K; Hansen JK; Villesen I; Bech K; Wernberg C; Andersen P; Lindvig KP; Tsochatzis EA; Thiele M; Rinella ME; Krag A;
    Lancet Gastroenterol Hepatol; 2024 Mar; 9(3):218-228. PubMed ID: 38218202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new Korean nomenclature for steatotic liver disease.
    Nonalcoholic Fatty Liver Disease (NAFLD) Nomenclature Revision Consensus Task Force on behalf of the Korean Association for the Study of the Liver (KASL)
    Clin Mol Hepatol; 2024 Sep; 30(Suppl):S214-S216. PubMed ID: 38946461
    [No Abstract]   [Full Text] [Related]  

  • 4. Advocating for the implementation of the new nomenclature for steatotic liver disease: A call to action for the national associations.
    Russo FP; Francque SM; Shawcross DL; Krag AA
    J Hepatol; 2024 Mar; 80(3):384-386. PubMed ID: 38122831
    [No Abstract]   [Full Text] [Related]  

  • 5. The new international nomenclature for steatotic liver disease: One step forward towards enhanced awareness for healthier life.
    van Erpecum KJ; van Kleef LA; Beuers U; de Knegt RJ
    Eur J Intern Med; 2023 Nov; 117():1-2. PubMed ID: 37714774
    [No Abstract]   [Full Text] [Related]  

  • 6. Heart-liver axis implications of the new steatotic liver disease nomenclature.
    Li P; Ji H; Cheng S
    Lancet Gastroenterol Hepatol; 2023 Dec; 8(12):1071-1072. PubMed ID: 37951235
    [No Abstract]   [Full Text] [Related]  

  • 7. A new era for steatotic liver disease: Evaluating the novel nomenclature in the UK Biobank.
    Schneider KM; Schneider CV
    J Hepatol; 2024 Feb; 80(2):e58-e60. PubMed ID: 37453612
    [No Abstract]   [Full Text] [Related]  

  • 8. Measuring the impact of the updated Steatotic liver disease nomenclature and definition.
    Valenti L; Aghemo A; Forner A; Petta S; Romeo S; Nahon P
    Liver Int; 2023 Nov; 43(11):2340-2342. PubMed ID: 37846803
    [No Abstract]   [Full Text] [Related]  

  • 9. [Metabolic steatotic liver disease: the move towards an inclusive definition].
    Zampaglione L; Marello N; Petignat PA
    Rev Med Suisse; 2024 Feb; 20(860):311-315. PubMed ID: 38323767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validating the new nomenclature of steatotic liver disease in patients with excessive alcohol intake.
    Wu Y; Fang F
    Lancet Gastroenterol Hepatol; 2024 May; 9(5):409. PubMed ID: 38604196
    [No Abstract]   [Full Text] [Related]  

  • 11. Validating the new nomenclature of steatotic liver disease in patients with excessive alcohol intake - Authors' reply.
    Israelsen M; Rinella ME; Krag A
    Lancet Gastroenterol Hepatol; 2024 May; 9(5):409-410. PubMed ID: 38604197
    [No Abstract]   [Full Text] [Related]  

  • 12. A New Korean Nomenclature for Steatotic Liver Disease.
    Nonalcoholic Fatty Liver Disease (NAFLD) Nomenclature Revision Consensus Task Force on behalf of the Korean Association for the Study of the Liver (KASL)
    Gut Liver; 2024 Sep; 18(5):924-925. PubMed ID: 39054914
    [No Abstract]   [Full Text] [Related]  

  • 13. [A New Korean Nomenclature for Steatotic Liver Disease].
    Nonalcoholic Fatty Liver Disease (NAFLD) Nomenclature Revision Consensus Task Force on behalf of the Korean Association for the Study of the Liver (KASL)
    Korean J Gastroenterol; 2024 Jul; 84(1):1-2. PubMed ID: 39049458
    [No Abstract]   [Full Text] [Related]  

  • 14. Embracing Change: From Nonalcoholic Fatty Liver Disease to Metabolic Dysfunction-Associated Steatotic Liver Disease Under the Steatotic Liver Disease Umbrella.
    Noureddin M; Wei L; Castera L; Tsochatzis EA
    Clin Gastroenterol Hepatol; 2024 Jan; 22(1):9-11. PubMed ID: 37848118
    [No Abstract]   [Full Text] [Related]  

  • 15. Steatotic liver disease predicts cardiovascular disease and advanced liver fibrosis: A community-dwelling cohort study with 20-year follow-up.
    Choe HJ; Moon JH; Kim W; Koo BK; Cho NH
    Metabolism; 2024 Apr; 153():155800. PubMed ID: 38266957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus.
    Chen L
    World J Hepatol; 2023 Dec; 15(12):1253-1257. PubMed ID: 38223415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More than additive effects on liver triglyceride accumulation by combinations of steatotic and non-steatotic pesticides in HepaRG cells.
    Lasch A; Marx-Stoelting P; Braeuning A; Lichtenstein D
    Arch Toxicol; 2021 Apr; 95(4):1397-1411. PubMed ID: 33575850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of Lipid Droplet Accumulation in Steatotic Liver Diseases.
    Dempsey JL; Ioannou GN; Carr RM
    Semin Liver Dis; 2023 Nov; 43(4):367-382. PubMed ID: 37799111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatty liver creates a pro-metastatic microenvironment for hepatocellular carcinoma through activation of hepatic stellate cells.
    Mikuriya Y; Tashiro H; Kuroda S; Nambu J; Kobayashi T; Amano H; Tanaka Y; Ohdan H
    Int J Cancer; 2015 Feb; 136(4):E3-13. PubMed ID: 25053237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examining the interim proposal for name change to steatotic liver disease in the US population.
    Ng CH; Chan KE; Muthiah M; Tan C; Tay P; Lim WH; Tan DJH; Fu CE; Yong JN; Wong ZY; Koh B; Chew NW; Syn N; Huang DQ; Dan YY; Siddiqui MS; Sanyal AJ; Noureddin M
    Hepatology; 2023 May; 77(5):1712-1721. PubMed ID: 36645228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.